Roche

AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
Endpoints
Mon, 06/11/18 - 09:17 am
AbbVie
Roche
Venclexta
Rituxan
CLL
chronic lymphocytic leukemia
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study
Fierce Pharma
Wed, 06/6/18 - 09:32 pm
Roche
MS
multiple sclerosis
Ocrevus
FDA
vaccines
ASCO18: Who were the big winners and losers?
Biopharma Dive
Wed, 06/6/18 - 04:06 pm
ASCO 2018
Merck
Loxo Oncology
Bluebird Bio
Celgene
Roche
Nektar
Roche scrambles to boost Herceptin supply in China after insurance OK triggers shortage
Fierce Pharma
Wed, 06/6/18 - 09:33 am
Roche
Herceptin
China
Roche dumps its PhIII PI3K effort on taselisib after researchers track poor survival edge, harsh side effects for breast cancer
Endpoints
Sun, 06/3/18 - 10:29 am
Roche
taselisib
fulvestrant
metastatic breast cancer
ASCO 2018
ASCO18: Tecentriq scores again in lung cancer, but Keytruda looms in background
Biopharma Dive
Sat, 06/2/18 - 01:39 pm
Roche
Tecentriq
ASCO 2018
chemotherapy
advanced squamous non-small cell lung cancer
Roche scraps €120M SMA drug after hitting ‘many difficulties’
Fierce Biotech
Fri, 06/1/18 - 11:25 pm
Roche
SMA
spinal muscular atrophy
Olesoxime
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
Wed, 05/30/18 - 09:13 pm
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
Biopharma Reporter
Wed, 05/30/18 - 08:29 pm
Celltrion
Rituxan
biosimilars
FDA
Herceptin
Roche
Biogen
CT-P10
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
Tue, 05/29/18 - 11:36 am
clinical trials
Roche
Genentech
Genmab
JNJ
cancer
Tecentriq
Darzalex
Roche’s Tecentriq scores again on a pivotal frontline lung cancer trial, positioning them against Merck, Bristol-Myers
Endpoints
Tue, 05/29/18 - 08:54 am
Roche
Tecentriq
anti-PD-L1
non-squamous non-small cell lung cancer
Merck
Bristol-Myers Squibb
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
RAPS.org
Tue, 05/22/18 - 11:06 am
Alzheimer's disease
FDA
Roche
AstraZeneca
Bioclinica
Eli Lilly
Denali Therapeutics
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
Biopharma Dive
Mon, 05/21/18 - 09:44 pm
FDA
clinical trials
oncologists
bladder cancer
Merck
Keytruda
Roche
Tecentriq
Roche drug dramatically reduces bleeds in key hemophilia tests
Reuters
Mon, 05/21/18 - 10:13 am
Roche
Hemlibra
clinical trials
hemophilia A
Roche pens death notice for NewLink IDO/TDO cancer collaboration
Fierce Biotech
Tue, 05/15/18 - 09:29 pm
Roche
NewLink Genetics
IDO/TDO inhibitors
drug development
Roche Tecentriq and Cotellic Combination Fails Ph III Trial in Colorectal Cancer
CP Wire
Thu, 05/10/18 - 09:57 am
Roche
Exelixis
Tecentriq
Cotellic
colorectal cancer
Roche Tecentriq and Cotellic Combination Fails Ph III Trial in Colorectal Cancer
Thu, 05/10/18 - 09:52 am
Roche
Exelixis
Tecentriq
Cotellic
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
Endpoints
Mon, 05/7/18 - 09:50 am
Roche
Tecentriq
FDA
Genentech
lung cancer
Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe
CP Wire
Thu, 05/3/18 - 09:33 am
Herzuma
biosimilars
trastuzumab
Europe
Herceptin
Roche
Mundipharma
Celltrion
Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers
Forbes
Wed, 05/2/18 - 10:49 am
Flatiron Health
M&A
Roche
Bristol-Myers Squibb
real-world evidence

Pages